Search Within

Elena Mead

Formats
  1. Meeting Abstract (29)
  2. Journal Article (21)
  3. Review (2)
  4. Correspondence (1)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. Anesthesiology and Critical Care Medicine (55)
  2. Critical Care Medicine (55)
  3. Nursing (35)
  4. Hematologic Malignancies, Division of (34)
  5. Advanced Practice Providers (33)
  6. Center for Hematologic Malignancies (33)

More Groups

People
  1. Bianca Santomasso (30)
  2. Jae Park (24)
  3. Miguel-Angel Perales (22)
  4. Renier Brentjens (22)
  5. Craig Sauter (21)
  6. Gunjan Shah (21)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (11)

More Years

Publications
  1. Critical Care Medicine (11)
  2. Blood (9)
  3. Biology of Blood and Marrow Transplantation (5)
  4. Blood Advances (4)
  5. Chest (3)
  6. American Journal of Respiratory and Critical Care Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Lippincott Williams & Wilkins (13)
  3. Elsevier Inc. (7)
  4. American College of Chest Physicians (3)
  5. Nature Publishing Group (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic impact of comorbidities on outcomes of patients (pts) with relapsed or refractory large B-cell lymphoma (r/r LBCL) treated with chimeric antigen receptor T-cell therapy (CART)
    Meeting Abstract

    Greenbaum, U.; Hashmi, H.; Elsawy, M.; Kim, S.; Moskop, A.; Awan, F. T.; Farooq, U.; Ganguly, S.; Hematti, P.; Jain, M. D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Critically ill patients treated for chimeric antigen receptor-related toxicity: A multicenter study
    Journal Article

    Gutierrez, C.; Brown, A. R. T.; May, H. P.; Beitinjaneh, A.; Stephens, R. S.; Rajendram, P.; Nates, J. L.; Pastores, S. M.; Dharshan, A.; de Moraes, A. G.; more...
    Critical Care Medicine (2022)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) cell patients admitted to the ICU: The CAR-ICU initiative experience
    Meeting Abstract

    Brown, A. R.; Rajendram, P.; Herr, M.; Hill, B.; Lin, Y.; Duggal, A.; May, H.; Beitinjaneh, A.; De Moraes, A. G.; Dharshan, A.; more...
    Critical Care Medicine (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
    Guidelines

    Maus, M. V.; Alexander, S.; Bishop, M. R.; Brudno, J. N.; Callahan, C.; Davila, M. L.; Diamonte, C.; Dietrich, J.; Fitzgerald, J. C.; Frigault, M. J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save